NEW ORLEANS -- A search for biomarkers to predict recurrence of ductal carcinoma in situ (DCIS) instead showed that a substantial fraction of recurrences had genetically distinct features from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback